Financial Highlights

Financial Highlights
2020 FQ3 YTD
9/30/2020
2019 FY
12/31/2019
2018 FY
12/31/2018
2017 FY
12/31/2017
2016 FY
12/31/2016
Balance Sheet ($000)
Cash and Cash Equivalents 15,057 11,809 5,676 6,644 7,368
Investments 104,979 118,969 112,690 114,731 112,657
Total Assets 155,556 153,934 144,231 146,438 148,579
Total Policy Reserves 85,806 78,472 77,988 76,674 76,174
Total Liabilities 108,494 100,473 98,365 98,813 100,527
Total Mezzanine Level Items 0 0 0 0 0
Equity Attributable to Parent Company 47,062 53,461 45,866 47,625 48,052
Total Equity 47,062 53,461 45,866 47,625 48,052
Equity before Unrealized Gains 43,559 50,967 47,251 44,499 46,366
Total Equity/ Total Assets(%) 30.25 34.73 31.80 32.52 32.34
Reserves/ Equity(x) 1.82 1.47 1.70 1.61 1.59
Income Statement ($000)
Total Policy Income 45,416 59,883 60,856 61,163 61,398
Net Investment Income 2,525 4,593 3,651 3,649 4,059
Realized Gain on Securities 1,272 2,338 (262) 232 831
Asset Management and Brokerage Fees 0 0 0 0 0
Total Revenue 49,663 67,399 64,857 65,640 66,893
Total Policy Expense 40,622 38,598 40,409 42,869 38,847
Underwriting & Other Expense 16,482 23,056 22,148 22,578 22,600
Total Expense 57,764 62,819 63,792 66,754 62,799
Net Income (6,364) 4,067 779 (1,203) 3,063
Net Income Attributable to Parent (6,364) 4,067 779 (1,203) 3,063
Operating Income after Taxes (7,145) 1,654 1,215 (1,355) 2,414
EBITDA (7,220) 6,110 2,612 707 5,749
Per Share Information ($)
Basic Book Value per Share 18.60 21.12 18.15 18.88 19.09
Book Value per Share before Unrealized Gains 17.21 20.14 18.70 17.64 18.42
Diluted EPS after Extraordinary (2.51) 1.61 0.31 (0.48) 1.22
EBITDA/ Share (2.85) 2.42 1.04 0.28 2.29
Operating EPS (2.82) 0.65 0.48 (0.54) 0.96
Price/ LTM Operating Earnings(x) NM 26.10 27.10 NM 18.50
Common Dividends Declared per Share 0.18 0.21 0.20 0.20 0.18
Dividend Payout Ratio(%) NM 13.04 64.52 NM 14.75
EPS after Extra Growth(%) NM 419.40 NM NM (34.80)
Profitability (%)
ROAA (5.56) 2.69 0.53 (0.81) 2.03
Operating ROAA (6.24) 1.09 0.83 (0.91) 1.60
ROAE (17.12) 8.02 1.67 (2.53) 6.36
ROATCE (17.12) 8.02 1.67 (2.53) 6.36
Operating ROAE (19.22) 3.26 2.60 (2.85) 5.01
Investment Yield 4.02 5.50 2.82 3.21 3.99
Combined Ratio 126.40 100.10 101.31 102.25 94.59
P&C Stat Combined Ratio after Dividends NA NA NA NA NA
Reported Medical Care Ratio NA NA NA NA NA
Net Premiums Written/ Avg Equity(x) 1.30 1.19 1.30 1.29 1.28
Growth Rates and Trends (%)
Asset Growth 1.40 6.73 (1.51) (1.44) 0.50
Equity Growth (15.96) 16.56 (3.69) (0.89) 7.06
Net Written Premium Growth 1.63 (0.50) (1.09) (0.22) 1.88
Recurring Revenue Growth (1.43) 3.92 (1.19) (1.87) 4.44
Net Income Growth NM 422.08 NM NM (34.79)
Assets Five-year CAGR 0.80 1.22 1.48 1.53 2.25
Equity Five-year CAGR 0.94 4.57 6.50 9.51 4.79
Revenue Five-year CAGR 0.59 0.92 1.18 1.98 1.50
Net Income Five-year CAGR NM (11.79) (32.72) NM NM
Miscellaneous ($000)
Net Premiums Written 48,188 60,411 60,717 61,388 61,525
Gross Life Insurance in Force NA 202,663 203,209 206,826 208,420
Total Membership(actual) 0 0 0 0 0
Assets Under Management 0 0 0 0 0
Data shown on this page is extracted directly from the company’s documents. S&P makes every effort to line up fields, captions and headers that represent the same data over time, despite variations in how the company may report these items in different documents. In certain instances the variation in the company’s presentation over time may be too significant, potentially resulting in repeating and/or disordered items. Despite possible issues with the presentation, S&P, as always, stands by its commitment to the quality of the data.
Copyright 2021, © S&P Global Market Intelligence  Terms of Use